Evidence map›Paper›PMID 37842893›Full record

ReviewCurrent pharmaceutical biotechnology2024

Main Aspects of Pharmaceutical Development of

Elena Bakhrushina, Iosif Mikhel, Valeriya Kondratieva, Natalia Demina, Tatyana Grebennikova, Ivan Krasnyuk, Ivan Krasnyuk

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Elena BakhrushinaInstitute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation.ORCID 0000-0001-8695-0346
Iosif MikhelInstitute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation.ORCID 0000-0002-2866-0049
Valeriya KondratievaCentre of Epidemiology and Microbiology, The Gamaleya National Centre of Epidemiology and Microbiology, Moscow, Russian Federation.ORCID 0000-0001-9163-4516
Natalia DeminaInstitute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation.ORCID 0000-0003-4307-8791
Tatyana GrebennikovaCentre of Epidemiology and Microbiology, The Gamaleya National Centre of Epidemiology and Microbiology, Moscow, Russian Federation.
Ivan KrasnyukInstitute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation.ORCID 0000-0001-8557-8829
Ivan KrasnyukInstitute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation.ORCID 0000-0002-7242-2988
Sechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe review presents the latest developments in the area of intranasal in situ delivery systems of immunobiological drugs (IBDs). Interest in intranasal administration for IBDs has increased significantly due to the COVID-19 pandemic. However, not only intranasal delivery of vaccines is developing, but also bacteriophages, interferons, etc.

methodsA scientific search was conducted on the PubMed database of medical publications for the period from 2000 to 2022, using the keywords "intranasal RESULTS AND

conclusionsDespite the large number of new studies, the potential of possibilities of intranasal

Indexed as

Administration, IntranasalAnimalsCOVID-19Drug Delivery SystemsDrug DevelopmentHumansSARS-CoV-2bacteriophagesimmunobiological drugsIn situ systemsinterferons.intranasal administrationintranasal vaccines

Identifiers

PMID37842893
OpenAlexW4387662057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.